A proteomic approach for the identification of bismuth-binding proteins in Helicobacter pylori
- 15 May 2007
- journal article
- Published by Springer Nature in JBIC Journal of Biological Inorganic Chemistry
- Vol. 12 (6) , 831-842
- https://doi.org/10.1007/s00775-007-0237-7
Abstract
Helicobacter pylori is a major human pathogen that can cause peptic ulcers and chronic gastritis. Bismuth-based triple or quadruple therapies are commonly recommended for the treatment of H. pylori infections. However, the molecular mechanisms underlying treatment with bismuth are currently not fully understood. We have conducted a detailed comparative proteomic analysis of H. pylori cells both before and after treatment with colloidal bismuth subcitrate (CBS). Eight proteins were found to be significantly upregulated or downregulated in the presence of CBS (20 μg mL−1). Bismuth-induced oxidative stress was confirmed by detecting higher levels of lipid hydroperoxide (approximately 1.8 times) and hemin (approximately 3.4 times), in whole cell extracts of bismuth-treated H. pylori cells, compared with those from untreated cells. The presence of bismuth also led to an approximately eightfold decrease in cellular protease activities. Using immobilized-bismuth affinity chromatography, we isolated and subsequently identified seven bismuth-binding proteins from H. pylori cell extracts. The intracellular levels of four of these proteins (HspA, HspB, NapA and TsaA) were influenced by the addition of CBS, which strongly suggests that they interact directly with bismuth. The other bismuth-interacting proteins identified were two enzymes (fumarase and the urease subunit UreB), and a translational factor (Ef-Tu). Our data suggest that the inhibition of proteases, modulation of cellular oxidative stress and interference with nickel homeostasis may be key processes underlying the molecular mechanism of bismuth’s actions against H. pylori.Keywords
This publication has 71 references indexed in Scilit:
- Inhibition of urease by bismuth(III): Implications for the mechanism of action of bismuth drugsBioMetals, 2006
- Proteomics of Metal Transport and Metal‐Associated DiseasesChemistry – A European Journal, 2006
- Inhibition of alcohol dehydrogenase by bismuth☆Journal of Inorganic Biochemistry, 2004
- Basis for the Management of Drug-Resistant Helicobacter pylori InfectionDrugs, 2004
- Serum biomarkers of hepatitis B virus infected liver inflammation: A proteomic studyProteomics, 2003
- Alternative and rescue treatment regimens for Helicobacter pylori eradicationExpert Opinion on Pharmacotherapy, 2002
- Ranitidine bismuth citrate: a novel anti-ulcer agent with different physico-chemical characteristics and improved biological activity to a bismuth citrate-ranitidine admixture.Alimentary Pharmacology & Therapeutics, 1996
- Use of an Ammonia Electrode for Rapid Quantification of Helicobacter pylori Urease: Its Use in the Endoscopy Room and in the Assessment of Urease Inhibition by Bismuth SubsalicylateDigestion, 1992
- Generation of Ammonia and Mucosal Lesion Formation Following Hydrolysis of Urea by Urease in the Rat StomachJournal of Clinical Gastroenterology, 1990
- Prevalence of Helicobacter pylori Infection and Histologic Gastritis in Asymptomatic PersonsNew England Journal of Medicine, 1989